Bull
$16.32
Scenario price
$4.970
0.000 (0.00%)At close
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs).
Barclays
$8
2025-03-31
Barclays
2025-03-31
Price Target
$8
JP Morgan
—
2025-02-24
JP Morgan
2025-02-24
Price Target
—
Wells Fargo
$5
2025-02-24
Wells Fargo
2025-02-24
Price Target
$5
Barclays
$40
2024-12-31
Barclays
2024-12-31
Price Target
$40
Barclays
$2
2024-11-15
Barclays
2024-11-15
Price Target
$2
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

bluebird bio, Inc. (BLUE) Nears Acquisition by Carlyle and SK Capital

Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal

Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

Carlyle, SK Capital, Beacon Set To Close Bluebird Bio Acquisition
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs). It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
18 analysts cover BLUE: 12 rate it Buy, 5 Hold and 1 Sell. The average price target is 8.00.

📅 October 11, 2026 | 10:17 PM PKT Hey Traders & Crypto Family! 👋 The weekend is ending, but the next altcoin move could bring fresh opportunities. I’m watching $S, $STRK, $2U2, $BLUE, and $CKB. The key is to identify real buying strength instead of chasing sudden pumps. 🔥 $S (Sonic) Sonic is on my watchlist as traders look for renewed momentum across altcoins. I’m watching trading volume, nearby resistance, and whether buyers can sustain the move. A confirmed breakout could improve the short-term outlook, while weak volume may signal a failed move. Patience is essential before considering an entry. ⚡ $STRK (Starknet) STRK deserves attention because sharp rallies can attract traders quickly. However, a strong green candle does not guarantee another rally. I’m watching whether price holds its breakout area and whether buying pressure remains consistent. If momentum weakens, profit-taking could trigger a pullback. Confirmation matters more than excitement. 👀 $2U2 For $2U2, the priority is checking the latest chart before making a directional prediction. Is trading volume increasing? Is price breaking resistance or facing repeated rejection? A breakout supported by strong volume would be more convincing than a sudden spike without follow-through. I prefer waiting for a clear signal rather than guessing. 💧 $BLUE BLUE needs careful monitoring of its support and resistance zones. If buyers defend support and volume improves, the setup could become more interesting. However, weakening momentum near resistance may indicate that sellers are returning. Always verify the correct token and trading pair before making a trading decision. 🚀 $CKB (Nervos Network) CKB has shown notable market activity, making it important to watch whether buyers can sustain the recovery. If price consolidates above support and volume remains healthy, further upside may be possible. However, sharp gains can also attract profit-taking. I’m focusing on price stability and confirmation instead of chasing a sudden pump. ⚡ MY STRATEGY I’m watching confirmation, volume, and support/resistance rather than blindly following green candles. Every coin has a different setup, and not every breakout is worth chasing. Pro Tip: Always check the latest Bitget chart before entering a trade. Protecting capital comes first, and no setup guarantees profits. dyor
Show more
🚨 TOP ALTCOIN GAINERS — Bulls Are Making Moves! 🚀 The altcoin market is heating up, with several tokens posting impressive gains. Here are three coins catching attention right now! 👀 🟢 1. BLUE/USDT 💰 Price: $0.01158 📈 Change: +26.42% 🔥 Leading this watchlist with the strongest percentage gain. 🟢 2. S/USDT 💰 Price: $0.05224 📈 Change: +19.57% ⚡ Strong upward momentum as traders watch for continuation. 🟢 3. TIA/USDT 💰 Price: $0.5825 📈 Change: +17.23% 🚀 Another strong mover worth watching for a potential breakout. 📊 Market Ranking 🥇 BLUE: +26.42% 🥈 S: +19.57% 🥉 TIA: +17.23% ⚠️ What to Watch: After sharp rallies, profit-taking and sudden pullbacks can happen. Watch trading volume, resistance levels, and whether prices can hold their recent gains before assuming the trend will continue. 🔥 Which one has the strongest potential for the next move — BLUE, S, or TIA? Educational purposes only. Not financial advice. $BLUE $S $TIA
Show more
BLUE Is Up 66%..... Can Bulls Break $0.01557? 👀 $STRK $CHIP 👉$BLUE has surged 66.48% to around $0.01515, pushing close to its 24-hour high and resistance at $0.01557. The rally is impressive, but RSI readings above 95 indicate extremely overheated momentum, so a sharp pullback cannot be ruled out. 📊 A confirmed breakout above $0.01557 could open the way toward $0.01632. If buyers lose strength, the $0.01464 area may be the first level to watch for support. 🤝💎Dyor
Show more
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.